Palantir price target raised to $200 from $150 at Rosenblatt

Rosenblatt raised the firm’s price target on Palantir (PLTR) to $200 from $150 and keeps a Buy rating on the shares. The U.S. government has ordered a six-month phase out period for Anthropic’s LLMs, which the firm thinks will leave “ample time” to switch over to one of the many other LLMs that are supported by Palantir, says the analyst, who thinks global instability and the need for comprehensive wartime solutions are likely to lead to deals like the U.S. army deal in July that rolled 75 contracts into just one with Palantir. Over time, the firm thinks the Middle East conflict is “likely to highlight the strength and leverage of Palantir’s solution vs. just another LLM,” the analyst added.